-
8921por Wagoner, Jessica, Morishima, Chihiro, Graf, Tyler N., Oberlies, Nicholas H., Teissier, Elodie, Pécheur, Eve-Isabelle, Tavis, John E., Polyak, Stephen J.“…A chemically modified and soluble version of silibinin, SIL, has been shown to potently reduce hepatitis C virus (HCV) RNA levels in vivo when administered intravenously. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
8922por Sugiyama, Masaya, Tanaka, Yasuhito, Wakita, Takaji, Nakanishi, Makoto, Mizokami, Masashi“…The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-α (PEG-IFNα) and ribavirin (RBV). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8923por Bilski, Bartosz“…A gradual reduction in the number of cases of hepatitis as an occupational disease has been noted since then. Currently, hepatitis C as an occupational disease is certified more frequently than hepatitis B. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8924por Huang, Cheng, Lokugamage, Kumari G., Rozovics, Janet M., Narayanan, Krishna, Semler, Bert L., Makino, Shinji“…Experiments using dicistronic mRNAs carrying different IRESes showed that nsp1 induced endonucleolytic RNA cleavage within the ribosome loading region of type I and type II picornavirus IRES elements, but not that of classical swine fever virus IRES, which is characterized as a hepatitis C virus-like IRES. The nsp1-induced RNA cleavage of template mRNAs exhibited no apparent preference for a specific nucleotide sequence at the RNA cleavage sites. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8925por Körner, Christian, Riesner, Katarina, Krämer, Benjamin, Eisenhardt, Marianne, Glässner, Andreas, Wolter, Franziska, Berg, Thomas, Müller, Tobias, Sauerbruch, Tilman, Nattermann, Jacob, Spengler, Ulrich, Nischalke, Hans Dieter“…To determine if gene variants in the TRAIL receptor I (DR4) gene affect the risk of hepatitis C virus (HCV)-induced liver cancer (HCC), we analysed DR4 mutations C626G (rs20575) and A683C (rs20576) in HCV-infected patients with and without HCC. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8926“…BACKGROUND: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8927por Barjon, Clément, Niki, Toshiro, Vérillaud, Benjamin, Opolon, Paule, Bedossa, Pierre, Hirashima, Mitsuomi, Blanchin, Stéphanie, Wassef, Michel, Rosen, Hugo R, Jimenez, Anne-Sophie, Wei, Ming, Busson, Pierre“…Excessive production of galectin-9 has been reported in two types of human virus-associated diseases chronic hepatitis C and nasopharyngeal carcinoma associated to the Epstein-Barr virus. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8928por Jeng, Wen-Juei, Lin, Chun-Yen, Chen, Ji-Yih, Huang, Chang-Wen, Huang, Chien-Hao, Sheen, I-Shyan“…METHOD: 197 CHC GT2 consecutive patients who received PR treatment in our prospective cohort were enrolled. Hepatitis C virus (HCV) genotyping, quantification of HCV-RNA and genotyping of the ten SNPs of IL28B were performed. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8929Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinomapor Soyemi, Olufemi Michael, Otegbayo, Jesse Abiodun, Ola, Samuel Olawale, Akere, Adegboyega, Soyemi, Temitope“….%) cases were positive for hepatitis C virus, while only 1(3.3%) out of 30 control was positive for hepatitis C virus(p = 0.74). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8930por Gravina, Antonietta Gerarda, Federico, Alessandro, Masarone, Mario, Cuomo, Antonio, Tuccillo, Concetta, Loguercio, Carmelina, Persico, Marcello, Romano, Marco“…This prospective study was designed to evaluate 1) the prevalence of coeliac disease in patients with HCV-related chronic hepatitis; 2) the prevalence of HCV infection in patients with coeliac disease; 3) whether PEG interferon-α treatment might favour the development of coeliac disease in patients with chronic hepatitis C. MATERIALS AND METHODS: Two hundred-ten consecutive patients (M/F = 140/70, range of age 35–58 years, median age 46.5 years) with biopsy proven chronic hepatitis C underwent serological screening for antiendomysial and tissue transglutaminase IgA antibodies. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8931por Zhang, Xiaozhen, Daucher, Marybeth, Armistead, David, Russell, Rodney, Kottilil, Shyam“…OBJECTIVE: Increasing evidence suggests that miRNAs have a profound impact on host defense to Hepatitis C virus (HCV) infection and clinical outcome of standard HCV therapy. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8932Etiologic and epidemiologic study of hepatocellular carcinoma in West Azarbaijan of Iran (2006–2011)“…None of the 60 patients with HCC had positive serology for hepatitis C virus (HCV) or history of hepatitis C infection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8933por Domagalski, K., Pawłowska, M., Tretyn, A., Halota, W., Pilarczyk, M., Smukalska, E., Linkowska, K., Grzybowski, T.“…IL-28B polymorphisms are predictors of response to therapy in adults infected with hepatitis C. We do not know whether they are markers of response to therapy in children and adolescents. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8934por Hahné, Susan JM, Veldhuijzen, Irene K, Wiessing, Lucas, Lim, Tek-Ang, Salminen, Mika, Laar, Marita van de“…BACKGROUND: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is improving but not benefiting individuals unaware to be infected. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8935por WAKUI, NORITAKA, TAKAYAMA, RYUJI, MATSUKIYO, YASUSHI, KAMIYAMA, NAOHISA, KOBAYASHI, KOJIRO, MUKOZU, TAKANORI, NAKANO, SHIGERU, IKEHARA, TAKASHI, NAGAI, HIDENARI, IGARASHI, YOSHINORI, SUMINO, YASUKIYO“…However, this case demonstrated that the peribiliary capillary plexus also regulates acute changes in portal venous blood flow, in addition to the chronic reduction in blood flow that is observed in patients with chronic hepatitis C.…”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8936por Rosenthal, Liana S., Skolasky, Richard L., Moxley, Richard T., Roosa, Heidi Vornbrock, Selnes, Ola A., Eschman, Amy, McArthur, Justin C., Sacktor, Ned“…After controlling for hepatitis C status and depression symptomatology, the tasks “following directions to the supermarket” and the “recalling which items to purchase” were no longer significant. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8937por Tesfaye, Abeba, Stift, Judith, Maric, Dragan, Cui, Qingwen, Dienes, Hans-Peter, Feinstone, Stephen M.“…While the chimpanzee remains the only animal that closely models human hepatitis C virus (HCV) infection, transgenic and immunodeficient mice in which human liver can be engrafted serve as a partial solution to the need for a small animal model for HCV infection. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8938por Goswami, Neela D., Pfeiffer, Christopher D., Horton, John R., Chiswell, Karen, Tasneem, Asba, Tsalik, Ephraim L.“…HIV-AIDS trials constitute the largest subset of ID trials (n = 815 [23%]), followed by influenza vaccine (n = 375 [11%]), and hepatitis C (n = 339 [9%]) trials. Relative to U.S. and global mortality rates, HIV-AIDS and hepatitis C virus trials are over-represented, whereas lower respiratory tract infection trials are under-represented in this large sample of ID clinical trials. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8939por Bhasin, Bhavna, Lau, Bryan, Atta, Mohamed G., Fine, Derek M., Estrella, Michelle M., Schwartz, George J., Lucas, Gregory M.“…Additionally eGFR(cys) bias and accuracy were strongly associated with use of antiretroviral therapy, HIV RNA suppression, and percentages of activated CD4 or CD8 T-cells. Hepatitis C seropositivity was associated with larger eGFR(cys) bias in both HIV-positive and HIV-negative groups. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8940por Norton, Brianna L, Voils, Corrine I, Timberlake, Sarah H, Hecker, Emily J, Goswami, Neela D, Huffman, Kim M, Landgraf, Anneka, Naggie, Susanna, Stout, Jason E“…BACKGROUND: In an attempt to curtail the rising morbidity and mortality from undiagnosed HCV (hepatitis C virus) in the United States, screening guidelines have been expanded to high-risk individuals and persons born 1945–1965. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto